Table 1.

General characteristics of controls subjects and subjects vaccinated with ChAdOx1-S.

	Control subjects	Vaccinated subjects without previous SARS-CoV-2 infection	Vaccinated subjects with previous SARS-CoV-2 infection	P -value
N	55	522	109
Age, years (SD)	39 (9)	40 (9)	39 (10)	n.s.
Sex, number of men (%)	4 (7%)	81 (15.5%)	11 (10.0%)	n.s.

Data are displayed as mean and standard deviation or as percentages in the case of categorical variables. Differences between the groups were analyzed by ANOVA. A p-value below 0.05 was considered statistically significant.